A Study to Evaluate the Safety and Effectiveness of JUVÉDERM Products in Adult Participants for the Change of Their Overall Facial Appearance

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

September 23, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
Mid Face Volume Deficit
Interventions
DEVICE

JUVÉDERM VOLUX XC

Injections

DEVICE

JUVÉDERM VOLUMA XC

Injections

DEVICE

JUVÉDERM VOLBELLA XC

Injections

DEVICE

JUVÉDERM VOLLURE XC

Injections

DEVICE

SKINVIVE by JUVÉDERM

Injections

DEVICE

JUVÉDERM ULTRA XC

Injections

DEVICE

JUVÉDERM ULTRA PLUS XC

Injections

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY